Get the Stockscreener App
21.96
0.72%
-0.16
After Hours:
21.79
-0.17
-0.77%
Omada Health Inc stock is traded at $21.96, with a volume of 180.11K.
It is down -0.72% in the last 24 hours and up +13.84% over the past month.
Omada Health Inc empowers individuals to make lasting health changes through personalized, virtual care between doctor's visits. The integrated platform of the company supports members with cardiometabolic conditions like prediabetes, diabetes, hypertension, musculoskeletal issues, and behavioral health needs. The company's specialized care tracks also assist members using GLP-1 medications. The Company delivers measurable health outcomes and value for employers, health plans, health systems, and pharmacy benefit managers.
See More
Previous Close:
$22.12
Open:
$22.2
24h Volume:
180.11K
Relative Volume:
0.31
Market Cap:
$1.26B
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-9.56%
1M Performance:
+13.84%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$21.87
$22.35
1-Week Range:
$21.11
$24.60
52-Week Range:
$14.14
$24.99
Omada Health Inc Stock (OMDA) Company Profile
Name
Omada Health Inc
Sector
Industry
Phone
888-987-8337
Address
500 SANSOME STREET, SAN FRANCISCO
Compare OMDA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
OMDA
Omada Health Inc
|
21.96 | 1.24B | 0 | 0 | 0 | 0.00 |
|
VEEV
Veeva Systems Inc
|
276.43 | 45.01B | 2.97B | 809.93M | 1.33B | 4.87 |
|
TEM
Tempus Ai Inc
|
86.38 | 13.58B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
71.03 | 12.92B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
92.49 | 7.88B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
37.36 | 7.06B | 906.14M | -52.62M | 89.62M | -0.3621 |
Omada Health Inc Stock (OMDA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-05-25 | Initiated | Robert W. Baird | Neutral |
| Jul-01-25 | Initiated | Barclays | Overweight |
| Jul-01-25 | Initiated | Canaccord Genuity | Buy |
| Jul-01-25 | Initiated | Evercore ISI | Outperform |
| Jul-01-25 | Initiated | Goldman | Buy |
| Jul-01-25 | Initiated | JP Morgan | Overweight |
| Jul-01-25 | Initiated | Morgan Stanley | Overweight |
| Jul-01-25 | Initiated | Needham | Buy |
View All
Omada Health Inc Stock (OMDA) Latest News
Omada Health (NASDAQ:OMDA) Stock Price Down 5.9%What's Next? - MarketBeat
Omada Health (NASDAQ:OMDA) Upgraded to Hold at Baird R W - MarketBeat
Omada simplifies and accelerates IGA deployment while lowering total cost of ownership - Yahoo Finance
United States 7MM Digital Therapeutics for Diabetes Market - openPR.com
Just 0.8% Weight Change: Omada Health's Groundbreaking Study Challenges Post-GLP-1 Weight Regain Assumptions - Stock Titan
Omada Health Develops Threat Model to Assess AI Risks in Healthcare - geneonline.com
Omada Health, Inc.(NasdaqGS: OMDA) added to NASDAQ Composite Index - MarketScreener
Baird initiates coverage on Omada Health stock with Neutral rating By Investing.com - Investing.com Australia
Omada Health shares fall 2.23% intraday after Baird initiates coverage with a Neutral rating and $24 price target. - AInvest
Baird Initiates Omada Health at Neutral With $24 Price Target - MarketScreener
Baird initiates coverage on Omada Health stock with Neutral rating - Investing.com
Heartflow, Inc. shares rise 2.21% premarket after new research from Omada Health demonstrates lower healthcare utilization and spending for patients using virtual physical therapy programs. - AInvest
Omada Health announce research on cost savings of virtual physical therapy - TipRanks
Omada Health Study Shows Virtual PT Saves on Medical Care and Costs. - AInvest
Omada Health Study Finds Virtual Physical Therapy Saves Significant Costs for Musculoskeletal Conditions - AInvest
New Research from Omada Health Demonstrates Significant Cost Savings of Virtual Physical Therapy - Yahoo Finance
$1,000+ Per Patient: Omada's Virtual Physical Therapy Outperforms Traditional Care in Major Cost Study - Stock Titan
Omada Health shares fall 1.75% premarket ahead of senior management's participation in Morgan Stanley's Global Healthcare Conference. - AInvest
Heartflow, Inc. shares rise 2.87% premarket after Omada Health's senior management participation in Morgan Stanley's Global Healthcare Conference. - AInvest
Omada Health shares rise 3.31% intraday after announcing participation in Morgan Stanley's Global Healthcare Conference. - AInvest
Omada Health to Participate in Upcoming Investor Conference - Yahoo Finance
Virtual Healthcare Leader Omada Health to Present at Morgan Stanley's 23rd Global Healthcare Conference - Stock Titan
Omada Health, Inc. (NASDAQ:OMDA) Receives $24.57 Average PT from Brokerages - MarketBeat
Healthcare Analysts Bullish on CSL, UnitedHealth, and Omada Health - AInvest
Omada Health stock rises on market debut - MSN
U.S. Digital Therapeutics Market Positioned for Accelerated - openPR.com
Digital health Q2 earnings: New guys win, GLP-1 companies lose - Modern Healthcare
Analysts Offer Insights on Healthcare Companies: Omada Health, Inc. (OMDA), Gilead Sciences (GILD) and Cytokinetics (CYTK) - The Globe and Mail
Omada Health, Inc.: Strong Market Position and Growth Potential Justify Buy Rating - TipRanks
Omada grows revenue, membership in public earnings debut - Healthcare Dive
Omada Health 2025 Q2 Earnings Losses Narrow Sharply, 50% Year-Over-Year Reduction in Net Loss - AInvest
Omada Health revenue jumps 49% year-over-year post-IPO - TechTarget
Goldman Sachs raises Omada Health stock price target to $31 on strong Q2 By Investing.com - Investing.com South Africa
Goldman Sachs raises Omada Health stock price target to $31 on strong Q2 - Investing.com Nigeria
Barclays raises Omada Health PT to $24, maintains Overweight rating. - AInvest
Freedom Broker lowers Omada Health stock price target to $20 from $26 - Investing.com India
Freedom Broker lowers Omada Health stock price target to $20 from $26 By Investing.com - Investing.com South Africa
Omada Health price target raised to $28 from $27 at Canaccord - TipRanks
Omada Health price target raised to $24 from $21 at Barclays - TipRanks
Omada Health Reports Strong Q2 2025 Growth - TipRanks
Omada Health reports Q2 EPS (24c), consensus (13c) - TipRanks
Omada Health beats on revenue in first earnings report since IPO - CNBC
Omada Health Reports Second Quarter 2025 Results - The Manila Times
Earnings Flash (OMDA) Omada Health, Inc. Reports Q2 Revenue $61.4M, vs. FactSet Est of $55.3M - MarketScreener
U.S. Digital Therapeutics Market to Witness Remarkable Growth - openPR.com
Omada Health, Inc. (NASDAQ:OMDA) Receives $23.86 Average PT from Analysts - Defense World
Omada Health’s Strategic Partnerships and AI Leverage Drive Growth and Profitability Outlook - TipRanks
Health Coach Market is evolving rapidly Through 2025 To 2032 | Noom, Inc., HealthifyMe, Omada Health - openPR.com
Digital Therapeutics for Diabetes Market is projected to reach - openPR.com
Omada Health: Long Growth Runway Ahead - Seeking Alpha
Omada Health: A Buy Rating for a Company with Strong Distribution Partnerships and Clinical Validation - AInvest
Omada Health Inc Stock (OMDA) Financials Data
There is no financial data for Omada Health Inc (OMDA). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
3.30%
0.78%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):